SETIADY, JULIANTO,PARK, PETER, U.,CHITTENDEN, THOMAS
申请号：
EP12850911
公开号：
EP2794010A4
申请日:
2012.11.21
申请国别(地区):
EP
年份:
2015
代理人:
摘要：
The present invention relates to the identification that EGFR antibody immunoconjugates are effective in inhibiting the growth of tumor cells that have developed EGFR and/or ALK resistance mechanisms. Methods of administering the EGFR antibody immunoconjugates to patients having resistant tumor cells is also disclosed.
